your market intelligence analyst
Search Results
21 results
Your search is now limited to «Inflammation» expert search.
Business Wire 06/03/2020 16:30
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients aged 12 and older with moderate to severe atopic dermatitis (AD).
Business Wire 06/02/2020 09:04
BALLERUP, Denmark & MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced it will present data – including Phase 3 clinical trials in atopic dermatitis (AD) and psoriasis - from its dermatology pipeline and portfolio at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020, June 12-14, 2020.

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.